NasdaqCM - Nasdaq Real Time Price USD

Galectin Therapeutics Inc. (GALT)

1.3800
-0.0200
(-1.43%)
At close: May 9 at 4:00:01 PM EDT
1.3800
0.00
(0.00%)
After hours: May 9 at 4:05:06 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
42,433
42,433
38,072
38,352
30,179
Operating Income
-42,433
-42,433
-38,072
-38,352
-30,179
Net Non Operating Interest Income Expense
-5,202
-5,202
-2,562
-981
-486
Other Income Expense
588
588
-432
557
138
Pretax Income
-47,047
-47,047
-41,066
-38,776
-30,527
Net Income Common Stockholders
-47,200
-47,200
-44,805
-38,873
-30,698
Diluted NI Available to Com Stockholders
-47,200
-47,200
-44,805
-38,873
-30,698
Basic EPS
-0.76
-0.76
-0.74
-0.65
-0.52
Diluted EPS
-0.76
-0.76
-0.74
-0.65
-0.52
Basic Average Shares
62,309
62,309
60,159
59,391
58,527
Diluted Average Shares
62,309
62,309
60,159
59,391
58,527
Total Operating Income as Reported
-42,433
-42,433
-38,072
-38,352
-30,179
Total Expenses
42,433
42,433
38,072
38,352
30,179
Net Income from Continuing & Discontinued Operation
-47,047
-47,047
-41,066
-38,776
-30,527
Normalized Income
-47,635
-47,635
-40,634
-39,333
-30,665
Interest Income
338
338
230
52
3
Interest Expense
5,540
5,540
2,792
1,033
489
Net Interest Income
-5,202
-5,202
-2,562
-981
-486
EBIT
-41,507
-41,507
-38,274
-37,743
-30,038
EBITDA
-41,470
-41,470
-38,241
-37,711
-29,997
Reconciled Depreciation
37
37
33
32
41
Net Income from Continuing Operation Net Minority Interest
-47,047
-47,047
-41,066
-38,776
-30,527
Total Unusual Items Excluding Goodwill
588
588
-432
557
138
Total Unusual Items
588
588
-432
557
138
Normalized EBITDA
-42,058
-42,058
-37,809
-38,268
-30,135
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/4/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AKRO Akero Therapeutics, Inc.
39.85
-5.99%
 
MDGL Madrigal Pharmaceuticals, Inc.
294.64
-1.65%
 
VTGN Vistagen Therapeutics, Inc.
2.2400
-0.44%
 
BIXT Bioxytran, Inc.
0.1500
+17.65%
 
SGMT Sagimet Biosciences Inc.
3.2600
+1.87%
 
GLMD Galmed Pharmaceuticals Ltd.
1.2400
-0.80%
 
GLTO Galecto, Inc.
2.7450
-1.96%
 
AUPH Aurinia Pharmaceuticals Inc.
8.00
-1.36%
 
LCTX Lineage Cell Therapeutics, Inc.
0.4400
-6.38%
 
MCRB Seres Therapeutics, Inc.
7.06
+1.44%